ETOPOSIDE-TEVA

Medicinal product

(Invented) name

ETOPOSIDE-TEVA

Active substance (s)

Etopozidas

Strength

20 mg/ml

Pharmaceutical form

koncentratas infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01CB01, Etoposide

Marketing authorisation holder

Teva Pharma B.V., Nyderlandai

Date of authorisation

1998-03-31

Date of renewal

2006-10-25

Documents

0585_1 ETOPOSIDE_TEVA konc inf PCS PL 2010505.docx

0585_1 Pakuotės lapelis 210505.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

1 ml koncentrato yra	1 ml
Etopozidas	20 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
15939	4042	1004042	flakonas	5 ml N1		Receptinis	LT/1/98/0585/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2021-10-28	Išregistruotas
2006-10-25	Perregistruotas
1998-03-31	Registruotas